Ono Pharmaceutical Co Ltd (4528):企業の財務・戦略的SWOT分析

【英語タイトル】Ono Pharmaceutical Co Ltd (4528) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C3057)・商品コード:DATA904C3057
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:52
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Ono Pharmaceutical Co Ltd (4528) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzheimer’s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others. The company offers products in various formulations such as capsules, tablets, injections, patches, dry syrup and intravenous infusion. Ono Pharmaceutical also has products in pipeline development. It offers its products in Americas, Europe and Asia . Ono Pharmaceutical is headquartered in Chuo-ku, Osaka, Japan.

Ono Pharmaceutical Co Ltd Key Recent Developments

Jul 13,2018: Ono Pharmaceutical: Support for the Torrential rain damage in Western Japan
Jul 09,2018: CluePoints Announces Four Year Partnership with ONO Pharmaceutical and Strengthens Risk-Based Monitoring Position in Japan
May 30,2018: Announcement on Establishment of Immune-mediated Inflammatory Diseases Consortium for Drug Development
May 30,2018: Daiichi Sankyo Announces Launch of Immune-mediated Inflammatory Diseases Consortium for Drug Development
May 30,2018: Notice Regarding Establishment of Immune-mediated Inflammatory Diseases Consortium for Drug Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Ono Pharmaceutical Co Ltd – Key Facts 6
Ono Pharmaceutical Co Ltd – Key Employees 7
Ono Pharmaceutical Co Ltd – Key Employee Biographies 8
Ono Pharmaceutical Co Ltd – Major Products and Services 9
Ono Pharmaceutical Co Ltd – History 11
Ono Pharmaceutical Co Ltd – Company Statement 18
Ono Pharmaceutical Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Section 2 – Company Analysis 21
Company Overview 21
Ono Pharmaceutical Co Ltd – Business Description 22
R&D Overview 22
Ono Pharmaceutical Co Ltd – SWOT Analysis 23
SWOT Analysis – Overview 23
Ono Pharmaceutical Co Ltd – Strengths 23
Ono Pharmaceutical Co Ltd – Weaknesses 24
Ono Pharmaceutical Co Ltd – Opportunities 25
Ono Pharmaceutical Co Ltd – Threats 26
Ono Pharmaceutical Co Ltd – Key Competitors 27
Section 3 – Company Financial Ratios 28
Financial Ratios – Capital Market Ratios 28
Financial Ratios – Annual Ratios 29
Performance Chart 32
Financial Performance 32
Financial Ratios – Interim Ratios 33
Financial Ratios – Ratio Charts 34
Section 4 – Company’s Lifesciences Financial Deals and Alliances 35
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 35
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 36
Ono Pharmaceutical Co Ltd, Recent Deals Summary 37
Section 5 – Company’s Recent Developments 38
Jul 13, 2018: Ono Pharmaceutical: Support for the Torrential rain damage in Western Japan 38
Jul 09, 2018: CluePoints Announces Four Year Partnership with ONO Pharmaceutical and Strengthens Risk-Based Monitoring Position in Japan 39
May 30, 2018: Daiichi Sankyo Announces Launch of Immune-mediated Inflammatory Diseases Consortium for Drug Development 40
May 30, 2018: Notice Regarding Establishment of Immune-mediated Inflammatory Diseases Consortium for Drug Development 41
May 30, 2018: Announcement on Establishment of Immune-mediated Inflammatory Diseases Consortium for Drug Development 42
May 10, 2018: Ono Pharmaceutical Co: Fiscal Year ended March 31, 2018 43
Apr 05, 2018: Ono Pharmaceutical Announce on Candidates of Members of the Board of Directors and Corporate Officers 44
Mar 01, 2018: Ono Pharmaceutical Announce Completion of a New Tokyo Building 45
Mar 01, 2018: Ono Pharmaceutical Announce Completion of a New Tokyo Building 46
Nov 09, 2017: Neurimmune Announces Collaboration with Ono Pharmaceutical in Neurodegenerative Diseases Field 47
Section 6 – Appendix 48
Methodology 48
Ratio Definitions 48
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Ono Pharmaceutical Co Ltd, Key Facts 6
Ono Pharmaceutical Co Ltd, Key Employees 7
Ono Pharmaceutical Co Ltd, Key Employee Biographies 8
Ono Pharmaceutical Co Ltd, Major Products and Services 9
Ono Pharmaceutical Co Ltd, History 11
Ono Pharmaceutical Co Ltd, Other Locations 19
Ono Pharmaceutical Co Ltd, Subsidiaries 20
Ono Pharmaceutical Co Ltd, Key Competitors 27
Ono Pharmaceutical Co Ltd, Ratios based on current share price 28
Ono Pharmaceutical Co Ltd, Annual Ratios 29
Ono Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 30
Ono Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 31
Ono Pharmaceutical Co Ltd, Interim Ratios 33
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 35
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 36
Ono Pharmaceutical Co Ltd, Recent Deals Summary 37
Currency Codes 48
Capital Market Ratios 48
Equity Ratios 49
Profitability Ratios 49
Cost Ratios 50
Liquidity Ratios 50
Leverage Ratios 51
Efficiency Ratios 51

List of Figures
Ono Pharmaceutical Co Ltd, Performance Chart (2014 - 2018) 32
Ono Pharmaceutical Co Ltd, Ratio Charts 34
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 35
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 36

★調査レポート[Ono Pharmaceutical Co Ltd (4528):企業の財務・戦略的SWOT分析] (コード:DATA904C3057)販売に関する免責事項を必ずご確認ください。
★調査レポート[Ono Pharmaceutical Co Ltd (4528):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆